Retraction of DNA Cell Biol: 31:1064-1069, 2012, DOI: 10.1089/dna.2011.1552;Fibroblast growth factor receptor 4 polymorphisms and susceptibility to coronary artery disease

DNA and Cell Biology

Volumn 31, Issue 6, 2012, Pages 1064-1069

  Ma, Lan ^a   Zhang, Haifeng ^b   Han, Carrie ^c   Tong, Danian ^d   Zhang, Meiyan ^a   Yao, Yi'An ^a   Luo, Yu ^a   Liu, Xuebo ^a  

^a TONGJI UNIVERSITY   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^c UNIVERSITY OF TORONTO   (Canada)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 4;

ADULT; ARTICLE; ATHEROSCLEROSIS; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE PREDISPOSITION; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

EID: 84864068768     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1552.ret     Document Type: Erratum

References (33)

1. Baird, A., Mormede, P., and Bohlen, P. (1985). Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. Biochem Biophys Res Commun 126, 358-364.
2. Bjornsson, T.D., Dryjski, M., Tluczek, J., Menniet, R., Ronant, J., Mellint, T.N., and Thomas, K.A. (1991). Acidic fibroblast growth factor promotes vascular repair. Proc Natl Acad Sci U S A 88, 8651-8655.
3. Casscells, W., Lappi, D.A., Olwin, B.B., Wai, C., Siegman, M., Speir, E.H., Sasse, J., and Baird, A. (1992). Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors. Proc Natl Acad Sci USA 89, 7159-7163.
4. Champion-Arnaud, P., Ronsin, C., Gilbert, E., Gesnel, M.C., Houssaint, E., and Breathnach, R. (1991). Multiple mRNAs code for proteins related to the BEK fibroblast growth factor receptor. Oncogene 6, 979-987.
5. Cuevas, P., Gonzalez, A.M., Carceller, F., and Baird, A. (1991). Vascular response to basic fibroblast growth factor when infused on to the normal adventitia or into the injured media of the rat carotid artery. Circ Res 69, 360-369.
6. Eisemann, A., Ahn, J.A., Graziani, G., Tronick, S.R., and Ron, D. (1991). Alternative splicing generates at least five different isoforms of the human basic-FGF receptor. Oncogene 6, 1195-1202.
7. Eswarakumar, V.P., Lax, I., and Schlessinger, J. (2005). Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16, 139-149.
8. Folkman, J., and Klagsbrun, M. (1987). Angiogenic factors. Science 235, 442-447.
9. Frullanti, E., Berking, C., Harbeck, N., Jézéquel, P., Haugen, A., Mawrin, C., Parise, O., Sasaki, H., Tsuchiya, N., and Dragani, T.A. (2011). Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor. Eur J Cancer Prev 20, 340-347.
10. Gaziano, T.A., Bitton, A., Anand, S., Abrahams-Gessel, S., and Murphy, A. (2010). Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol 35, 72-115.
11. Hughes, S.E., Crossman, D., and Hall, P.A. (1993). Expression of basic and acidic fibroblast growth factors and their receptor in normal and atherosclerotic human arteries. Cardiovasc Res 27, 1214-1219.
12. Jaakkola, S., Salmikangas, P., Nylund, S., Partanen, J., Armstrong, E., Pyrhonen, S., Lehtovirta, P., and Nevanlinna, H. (1993). Amplification of fgfr4 gene in human breast and gynecological cancers. Int J Cancer 54, 378-382.
13. Jackson, C.L., and Reidy, M.A. (1993). Basic fibroblast growth factor: its role in the control of smooth muscle cell migration. Am J Pathol 143, 1024-1031.
14. Lehtola, L., Partanen, J., Sistonen, L., Korhonen, J., Warri, A., Harkonen, P., Clarke, R., and Alitalo, K. (1992). Analysis of tyrosine kinase mRNAs including four FGF receptor mRNAs expressed in MCF-7 breast-cancer cells. Int J Cancer 50, 598-603.
15. Leung, H.Y., Gullick, W.J., and Lemoine, N.R. (1994). Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer. Int J Cancer 59, 667-675.
16. Lindner, V., Lappi, D.A., Baird, A., Majack, R.A., and Reidy, M.A. (1991). Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 68, 106-113.
17. Liu, Y., He, Z., Feng, D., Shi, G., Gao, R., Wu, X., Song, W., and Yuan, W. (2011). Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma. DNA Cell Biol 30, 1051-1055.
18. Ma, L., Song, H., Zhang, M., and Zhang, D. (2011). Lysyl oxidase G473A polymorphism is associated with increased risk of coronary artery diseases. DNA Cell Biol 30, 1033-1037.
19. Matsumoto-Yoshitomi, S., Habashita, J., Nomura, C., Kuroshima, K., and Kurokawa, T. (1997). Autocrine transformation by fibroblast growth factor 9 (FGF-9) and its possible participation in human oncogene. Int J Cancer 71, 442-450.
20. Mikawa, T. (1995). Retroviral targeting of FGF and FGFR in cardiomyocytes and coronary vascular cells during heart development. Ann N Y Acad Sci 752, 506-516.
21. Nabel, E.G., Yang, Z., Plautz, G., Forough, R., Zhan, X., Haudenschild, C.C.,Maciag, T., and Nabel, G.J. (1993). Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature 362, 844-846.
22. Reidy, M.A., and Lindner, V. (1991). Basic FGF and growth of arterial cells. Ann N Y Acad Sci 638, 290-299.
23. Schweigerer, L., Neufeld, G., Friedman, J., Abraham, J.A., Fiddes, J.C., and Gospodarowicz, D. (1987). Capillary endothelial cells express basic fibroblastgrowth factor, a mitogen that promotes their own growth. Nature 325, 257-259.
24. Shi, Y.Y., and He, L. (2005). SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15, 97-98.
25. Takahashi, A., Sasaki, H., Kim, S.J., Kakizoe, T., Miyao, N., Sugimura, T., Terada, M., and Tsukamoto, T. (1999). Identification of receptor genes in renal cell carcinoma associated with angiogenesis by differential hybridization technique. Biochem Biophys Res Commun 257, 855-859.
26. Tan, E.M.L., Levine, E., Sorger, T., Unger, G.A., Hacobian, N., Planck, B., and Iozzo, R.V. (1989). Heparin and endothelial cell growth factor modulate collagen and proteoglycan production in human smooth muscle cells. Biochem Biophys Res Commun 163, 84-92.
27. Templeton, T.J., and Hauschka, S.D. (1992). FGF-mediated aspects of skeletal muscle growth and differentiation are controlled by a high affinityreceptor, FGFRI. Dev Biol 154, 169-181.
28. Wang, J., Yu, W., Cai, Y., Ren, C., and Ittmann, M.M. (2008). Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression. Neoplasia 10, 847-856.
29. Wang, W., Song, H., Liu, J., Song, B., and Cao, X. (2011). CD86 + 1057G/A Polymorphism and Susceptibility to Osteosarcoma. DNA Cell Biol 30, 925-929.
30. Werner, S., Duan, D.S., De Vries, C., Peters, K.G., Johnson, D.E., and Williams, L.T. (1992). Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol Cell Biol 12, 82-88.
31. Winkles, J.A., Friesel, R., Burgess, W.H., Richard, H., Mehlman, T., Weinstein R., and Maciag, T. (1987). Human vascular smooth muscle cells both express and respond to heparinbinding growth factor I (endothelial cell growth factor). Proc Natl Acad Sci USA 84, 7124-7128.
32. Xu, W., Li, Y., Wang, X., Chen, B., Wang, Y., Liu, S., Xu, J., Zhao, W., and Wu, J. (2010). FGFR4 transmembrane domain polymorphism and cancer risk: a meta-analysis including 8555 subjects. Eur J Cancer 46, 3332-3338.
33. Yang, Y., Zhou, Y., Lu, M., An, Y., Li, R., Chen, Y., Lu, D.R., Jin, L., Zhou, W.P., Qian, J., and Wang, H.Y. (2011). Association between fibroblast growth factor receptor 4 polymorphisms and risk of hepatocellular carcinoma. Mol Carcinog [Epub ahead of print]; DOI: 10.1002/mc.20805.